Neuros Medical, Inc.

Aliso Viejo, CA · Founded 2008 · Medtech · Private

FDA-approved neuromodulation device for chronic post-amputation pain control

Claim this profile

Follows are private to you and power your alerts

Updated · neurosmedical.com

Sector
Medtech
Headquarters
Aliso Viejo, CA
Founded
2008
Latest Form D
$56M, Aug 2025
Total capital
$154M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$154M
12 Form D · last Aug 2025
15 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
9
12 pending · first 2020
Rank in peer group#218 of 1112

Capital timeline

20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $160M4th Form D$6M
20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $160M

Latest events

  • Private capital raisedForm D · SEC · 11th filing$56M
  • Private capital raisedForm D · SEC · 10th filing$20M
  • Private capital raisedForm D · SEC · 9th filing$8.2M
  • Private capital raisedForm D · SEC · 8th filing$37M
  • Private capital raisedForm D · SEC · 7th filing$2.2M
  • Private capital raisedForm D · SEC · 6th filing$2.4M
  • Private capital raisedForm D · SEC · 5th filing$22.6M
  • Offering registeredForm D · SEC · 4th filing$6M
  • Private capital raisedForm D · SEC · 3rd filing$1.8M
  • Private capital raisedForm D · SEC · 2nd filing$2.5M
  • Private capital raisedForm D · SEC · 1st filing$1.3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#218 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alan J. KaganovDirectorNamed in SEC Form D filings
  • Anthony J. NataleDirectorNamed in SEC Form D filings
  • Casey C. TanseyDirectorNamed in SEC Form D filings
  • Claiborne R. RankinDirectorNamed in SEC Form D filings
  • David VeinoExecutive Officer, DirectorNamed in SEC Form D filings
  • Fouad AzzamDirectorNamed in SEC Form D filings
Show all 18 people
  • Jon J. SnyderExecutive Officer, DirectorNamed in SEC Form D filings
  • Joseph J. JankowskiDirectorNamed in SEC Form D filings
  • Joyce C. EronyDirectorNamed in SEC Form D filings
  • Marc-Andre C. MarcotteDirectorNamed in SEC Form D filings
  • Mark W. TeagueExecutive OfficerNamed in SEC Form D filings
  • Randy BanDirectorNamed in SEC Form D filings
  • Robert J. CentaExecutive OfficerNamed in SEC Form D filings
  • Scott F. DreesDirectorNamed in SEC Form D filings
  • Stephen R. HaynesDirectorNamed in SEC Form D filings
  • Thomas C. WilderExecutive Officer, DirectorNamed in SEC Form D filings
  • William C. HarringtonDirectorNamed in SEC Form D filings
  • Zach StassenExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 9 granted of 21
  • PendingApparatuses And Methods For Setting An Electrical DoseUSPTOApplication 19122706
  • PendingApparatuses And Methods For Setting An Electrical DoseUSPTOApplication 18974509
  • GrantedApparatuses And Methods For Setting An Electrical DoseUSPTOUS 12,201,837
Show all 21 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .